Evaluating an eHealth Solution for Screening in Pediatric Care

Sponsor
Children's Hospital of Philadelphia (Other)
Overall Status
Recruiting
CT.gov ID
NCT04506294
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH), University of Kentucky (Other), Radiant Creative Group, LLC (Other)
300
2
2
22
150
6.8

Study Details

Study Description

Brief Summary

This study will evaluate the predictive validity of a game-based screening system based on child self-report measures.

The core study hypotheses are that (1) in-game assessments will predict problematic recovery (child pain and posttraumatic stress symptoms [PTSS]) and (2) parents in the intervention group will report greater confidence in managing child recovery.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: eScreen system
N/A

Detailed Description

This study will evaluate the predictive validity of a game-based screening system based on child self-report measures.

The core study hypotheses are that (1) in-game assessments will predict problematic recovery (child pain and PTSS) and (2) parents in the intervention group will report greater confidence in managing child recovery.

Study Design:

This study is a randomized controlled trial that will examine validity of eScreen measures (primary aim) and assess the impact of the eScreen system on parent confidence in managing child symptoms and recovery (secondary aim).

At T1, after baseline assessment (questionnaires), children will be randomized to the usual care plus eScreen (eScreen) or usual care alone (Usual Care) groups. In the eScreen group, children will use the game-based screening component and parents the parent information component for 6 weeks. All participants will complete follow-up research assessments by phone, online, or mail at T2 (6 weeks) and T3 (12 weeks). Following their T3 research assessment, child participants in the Usual Care group will have the option to play and provide feedback on the game (with no in-game assessment and no parent information component).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
300 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Screening
Official Title:
Evaluating an eHealth Solution for Screening in Pediatric Care
Actual Study Start Date :
Jan 29, 2021
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: eScreen Group

After randomization at baseline, use eScreen system (child screening component and parent information component) for 6 weeks.

Behavioral: eScreen system
The eScreen system is composed of a child screening component and a parent information component. The child screening component is delivered via a game-like interface and includes assessment of current pain, PTSS, and functional recovery. Children are asked to play the game at least 3x/week. The parent information component consists of text / email messages sent to parents at least weekly that summarize child ratings and include a link to an online dashboard with additional personalized information for parents.

No Intervention: Usual Care Group

Treatment as usual from baseline. Optional access to the game only (no screening, no parent information component) after completion of T3 assessment (~12 weeks)

Outcome Measures

Primary Outcome Measures

  1. Predictive validity of eScreen pain measure for clinically significant pain severity at 6 weeks [6 weeks]

    Evaluate predictive validity, measured as area under the curve (AUC) in receiver operating curve (ROC) analyses, for eScreen pain measure score (range 0-10) predicting presence of clinically significant pain intensity (score >=6 on the Numerical Rating Scale; NRSI) at 6 weeks.

  2. Predictive validity of eScreen pain measure for clinically significant pain interference at 6 weeks [6 weeks]

    Evaluate predictive validity, measured as area under the curve (AUC) in receiver operating curve (ROC) analyses, for eScreen pain measure score (range 0-10) predicting presence of clinically significant pain interference (T score >=65 on the PROMIS Pediatric Pain Interference scale - child report) at 6 weeks.

  3. Predictive validity of eScreen posttraumatic stress measure for clinically significant posttraumatic stress symptoms at 6 weeks [6 weeks]

    Evaluate predictive validity, measured as area under the curve (AUC) in receiver operating curve (ROC) analyses, for eScreen-administered posttraumatic stress measure (range 0-12) predicting presence of clinically significant posttraumatic stress symptoms at 6 weeks, scored from symptom count on the Child PTSD Symptom Scale for DSM-5 [CPSS-5].

  4. Predictive validity of eScreen posttraumatic stress measure for impairment from posttraumatic stress symptoms at 6 weeks [6 weeks]

    Evaluate predictive validity, measured as area under the curve (AUC) in receiver operating curve (ROC) analyses, for eScreen-administered posttraumatic stress measure (range 0-12) predicting presence of impairment from posttraumatic stress symptoms at 6 weeks, scored from impairment items on the Child PTSD Symptom Scale for DSM-5 [CPSS-5].

Secondary Outcome Measures

  1. Impact of eScreen system on parent confidence in managing child symptoms and recovery [6 weeks]

    Examine difference between (randomly assigned) eScreen and usual care groups on a measure of parents' self-rated confidence in managing child symptoms and recovery. Effect size (Cohen's d) calculated as the between-group difference in summed ratings on the Parent Information / Confidence Questionnaire, standardized by the pooled standard deviation (SD) for the groups.

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Child treated or admitted for injury or illness event that occurred within the past month

  • Child has regular access to a compatible (IOS or Android) tablet at home

  • Parent has an internet-capable smartphone and can receive text messages on that phone, OR has email account that can receive messages about child status

  • Child and parent read or understand English well enough to consent / assent to participation and complete study tasks (e.g., checklists, use of screening system)

Exclusion Criteria:
  • Index medical event is due to family violence

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kentucky Children's Hospital Lexington Kentucky United States 40536
2 Children's Hospital of Philadelphia Philadelphia Pennsylvania United States 19146

Sponsors and Collaborators

  • Children's Hospital of Philadelphia
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • University of Kentucky
  • Radiant Creative Group, LLC

Investigators

  • Principal Investigator: Nancy Kassam-Adams, PhD, Center for Injury Research & Prevention, Children's Hospital of Philadelphia

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier:
NCT04506294
Other Study ID Numbers:
  • 20-017351
  • R42HD087021
First Posted:
Aug 10, 2020
Last Update Posted:
Feb 18, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 18, 2022